UBS (Lux) Equity Fund - Sustainable Health Transformation (USD) Q-acc

Reference Data

ISIN LU0358044559
Valor Number 3932901
Bloomberg Global ID UBSEHBP LX
Fund Name UBS (Lux) Equity Fund - Sustainable Health Transformation (USD) Q-acc
Fund Provider UBS Asset Management Switzerland AG, Zurich 8098 Zürich, Schweiz
E-Mail: ubs-am-wholesale-switzerland@ubs.com
Web: www.ubs.com/fonds
Fund Provider UBS Asset Management Switzerland AG, Zurich
Representative in Switzerland UBS Fund Management (Switzerland) AG
Basel
Phone: +41 61 288 49 10
Distributor(s) UBS Global Asset Management
Basel
Phone: +41 61 288 20 20
Asset Class Equities
EFC Category Equity Health Care
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The Fund’s investment objective consists in generating strong capital appreciation with a reasonable level of income, while giving due consideration to capital security and the liquidity of the Fund’s assets. This sub-fund is a Sustainability Focus Fund. This sub-fund promotes environmental and/or social characteristics and complies with Article 8 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (“SFDR”). This actively managed sub-fund invests at least two thirds of its assets worldwide in shares or other equity interests of companies in developed or emerging markets, which mainly promote United Nations Sustainable Development Goal 3 (Good Health and Well-Being). The focus is on companies that capitalise on healthcare transformation.
Peculiarities

Fund Prices

Current Price * 287.68 USD 30.01.2025
Previous Price * 283.93 USD 29.01.2025
52 Week High * 299.10 USD 30.08.2024
52 Week Low * 251.39 USD 17.04.2024
NAV * 287.68 USD 30.01.2025
Issue Price * 287.68 USD 30.01.2025
Redemption Price * 287.68 USD 30.01.2025
Closing Price *
Indicative Minimum Price
Fund Assets *** 236,507,877
Unit/Share Assets *** 52,900,780
Trading Information SIX

Performance

YTD Performance +8.80% 31.12.2024
30.01.2025
YTD Performance (in CHF) +9.04% 31.12.2024
30.01.2025
1 month +9.05% 30.12.2024
30.01.2025
3 months +2.90% 30.10.2024
30.01.2025
6 months -0.68% 30.07.2024
30.01.2025
1 year +11.09% 30.01.2024
30.01.2025
2 years +21.93% 30.01.2023
30.01.2025
3 years +20.85% 31.01.2022
30.01.2025
5 years +50.95% 30.01.2020
30.01.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 9.76%
UnitedHealth Group Inc 9.68%
AstraZeneca PLC 6.03%
Intuitive Surgical Inc 5.53%
Koninklijke Philips NV 4.87%
Bristol-Myers Squibb Co 4.61%
Chugai Pharmaceutical Co Ltd 4.52%
Sandoz Group AG Registered Shares 4.43%
Alcon Inc 4.37%
Novartis AG Registered Shares 3.69%
Last data update 31.12.2024

Cost / Risk

TER 0.99%
TER date 30.11.2023
Performance Fee *** 0.00%
PTR
Max. Management Fee *** 0.73%
Ongoing Charges *** 0.99%
SRRI ***
SRRI date *** 31.12.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)